| Literature DB >> 33131544 |
Stephanie B Dixon1, Eric J Chow2, Lars Hjorth3, Melissa M Hudson4, Leontien C M Kremer5, Lindsay M Morton6, Paul C Nathan7, Kirsten K Ness8, Kevin C Oeffinger9, Gregory T Armstrong8.
Abstract
As treatment evolves and the population who survive childhood cancer ages and increases in number, researchers must use novel approaches to prevent, identify and mitigate adverse effects of treatment. Future priorities include collaborative efforts to pool large cohort data to improve detection of late effects, identify late effects of novel therapies, and determine the contribution of genetic factors along with physiologic and accelerated aging among survivors. This knowledge should translate to individual risk prediction and prevention strategies. Finally, we must utilize health services research and implementation science to improve adoption of survivorship care recommendations outside of specialized pediatric oncology centers.Entities:
Keywords: Adolescent; Cancer; Child; Delivery of health care; Neoplasms; Survivor; Treatment outcome
Year: 2020 PMID: 33131544 PMCID: PMC7773506 DOI: 10.1016/j.pcl.2020.07.013
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278